Knowledge (XXG)

NovoBiotic Pharmaceuticals

Source đź“ť

63:, and licensed to NovoBiotic Pharmaceuticals. Over the years NovoBiotic has amassed a large collection of previously uncultivated microorganisms utilizing the diffusion chamber, and screens them for antibiotic activity. NovoBiotic holds the patent rights to any potentially useful molecules that are extracted, identified and characterized. This approach has resulted the discovery of several new antibiotic compounds, including teixobactin. 183: 197:
Ling, Losee; Schneider, Tanja; Peoples, Aaron; Spoering, Amy; Engels, Ina; Conlon, Brian; Mueller, Anna; Schäberle, Till; Hughes, Dallas; Epstein, Slava; Jones, Michael; Lazarides, Linos; Steadman, Victoria; Cohen, Douglas; Felix, Cintia; Fetterman, K. Ashley; Millett, William; Nitti, Anthony; Zullo,
50:
The founders had led the development of new techniques to search for useful molecules produced by the untapped vast majority of soil and marine bacteria that cannot be initially cultured in the laboratory. They developed diffusion chambers
90:
to available approved antibiotics. The discovery and characterization of the compound was reported in 2015 in a collaboration between NovoBiotic, Northeastern University (Boston MA), University of Bonn (Germany) and Selcia Ltd. (UK).
336: 42:, while Epstein is on the faculty of the Department of Biology. Both Lewis and Epstein are paid consultants to this company. The focus of the company is on the discovery of new antibiotics and oncology drugs. 329: 250: 1113: 345: 322: 1118: 827: 817: 807: 797: 787: 777: 767: 757: 747: 103:
to relatively mutable proteins in the bacterial cells, it binds to less mutable fatty molecules that are essential cell wall precursors.
151: 22:
is a privately held, early-stage biotechnology company focused on the discovery and development of new drugs from natural sources.
1092: 960: 499: 181:, "Novel depsipeptide and uses thereof", published 12 June 2014, assigned to Novobiotic Pharmaceuticals LLC 718: 1075: 529: 39: 524: 698: 668: 653: 581: 566: 504: 449: 965: 673: 414: 257: 31: 1030: 880: 601: 591: 586: 444: 384: 60: 35: 985: 955: 905: 860: 708: 399: 83: 178: 1060: 865: 683: 648: 494: 474: 1020: 995: 945: 940: 920: 870: 803: 793: 663: 638: 546: 541: 509: 439: 409: 1045: 1010: 1000: 925: 910: 633: 628: 369: 359: 970: 783: 753: 703: 469: 454: 251:"NovoBiotic reports the discovery of teixobactin, a new antibiotic without detectable resistance" 156: 121: 314: 950: 915: 404: 231: 122:"The Unseen: Millions of microbes are yet to be discovered. Will one hold the ultimate cure?" 678: 616: 596: 551: 536: 479: 221: 213: 204: 59:, so that they could then be extracted for study. A patent for these techniques is held by 1025: 935: 930: 571: 519: 489: 87: 855: 561: 226: 199: 52: 1107: 1035: 833: 735: 643: 813: 100: 99:
of the target pathogens because of its unusual antibiotic mechanism. Rather than
38:
professors Kim Lewis and Slava Epstein. Lewis is the director of Northeastern’s
1005: 688: 556: 92: 72: 1065: 693: 424: 76: 1015: 885: 658: 623: 484: 459: 283: 235: 55:) to be embedded in natural settings to grow "uncultivable" microorganisms 895: 890: 773: 763: 434: 96: 80: 217: 1050: 900: 823: 743: 713: 611: 576: 514: 429: 389: 374: 1055: 990: 980: 875: 606: 419: 364: 1070: 1040: 975: 464: 394: 379: 850: 284:"Antibiotics: US discovery labelled 'game-changer' for medicine" 200:"A new antibiotic kills pathogens without detectable resistance" 318: 310: 152:"From a Pile of Dirt, Hope for a Powerful New Antibiotic" 71:
NovoBiotic Pharmaceuticals owns the patent rights to
843: 734: 727: 352: 198:Ashley; Chen, Chao; Lewis, Kim (7 January 2015). 1114:Pharmaceutical companies of the United States 346:Pharmaceutical companies of the United States 330: 8: 1119:Health care companies based in Massachusetts 731: 337: 323: 315: 225: 79:that has been shown to be active against 112: 260:, MA (USA): NovoBiotic Pharmaceuticals 120:Khatchadourian, Raffi (20 June 2016). 95:is believed to be more robust against 277: 275: 145: 143: 7: 282:Gallagher, James (7 January 2015). 30:The company was founded in 2003 in 624:Pharmaceutical Product Development 14: 1093:List of pharmaceutical companies 40:Antimicrobial Discovery Center 16:American biotechnology company 1: 500:Institute for OneWorld Health 249:Lewis, Kim (7 January 2015). 46:Research and drug development 719:West Pharmaceutical Services 1135: 525:McNeil Consumer Healthcare 20:NovoBiotic Pharmaceuticals 1088: 1031:Smith, Kline & French 582:Northwest Biotherapeutics 567:Merrimack Pharmaceuticals 61:Northeastern University 36:Northeastern University 26:Early history and focus 956:Leiner Health Products 400:Amneal Pharmaceuticals 128:. New York: CondĂ© Nast 84:Gram-positive bacteria 510:Johnson & Johnson 804:Jazz Pharmaceuticals 794:Horizon Therapeutics 664:Sarepta Therapeutics 639:Proteon Therapeutics 634:Procter & Gamble 547:Melinta Therapeutics 440:Bristol Myers Squibb 86:that have developed 1011:Repros Therapeutics 926:Forest Laboratories 911:Cutter Laboratories 629:Prasco Laboratories 370:Acorda Therapeutics 360:Abbott Laboratories 306:External References 218:10.1038/nature14098 971:Miles Laboratories 961:Martek Biosciences 784:Endo International 704:Ventria Bioscience 470:Danco Laboratories 311:Official home page 157:The New York Times 1101: 1100: 1084: 1083: 916:DNAPrint Genomics 405:Avax Technologies 1126: 732: 679:Tec Laboratories 552:Melior Discovery 537:Kinetic Concepts 480:Galena Biopharma 339: 332: 325: 316: 299: 298: 296: 294: 279: 270: 269: 267: 265: 255: 246: 240: 239: 229: 194: 188: 187: 186: 182: 175: 169: 168: 166: 164: 147: 138: 137: 135: 133: 117: 1134: 1133: 1129: 1128: 1127: 1125: 1124: 1123: 1104: 1103: 1102: 1097: 1080: 1026:Schering-Plough 936:ImClone Systems 839: 723: 572:Myriad Genetics 562:Merck & Co. 520:Janssen Biotech 490:Gilead Sciences 348: 343: 308: 303: 302: 292: 290: 281: 280: 273: 263: 261: 253: 248: 247: 243: 212:(7535): 455–9. 196: 195: 191: 184: 177: 176: 172: 162: 160: 150:Denise, Grady. 149: 148: 141: 131: 129: 119: 118: 114: 109: 69: 53:isolation chips 48: 34:, MA (USA), by 28: 17: 12: 11: 5: 1132: 1130: 1122: 1121: 1116: 1106: 1105: 1099: 1098: 1096: 1095: 1089: 1086: 1085: 1082: 1081: 1079: 1078: 1073: 1068: 1063: 1058: 1053: 1048: 1043: 1038: 1033: 1028: 1023: 1018: 1013: 1008: 1003: 998: 993: 988: 983: 978: 973: 968: 963: 958: 953: 948: 943: 938: 933: 928: 923: 918: 913: 908: 903: 898: 893: 888: 883: 878: 873: 868: 863: 858: 856:Allergan, Inc. 853: 847: 845: 841: 840: 838: 837: 836:(Canada, 2010) 831: 821: 811: 801: 791: 781: 771: 761: 751: 740: 738: 729: 725: 724: 722: 721: 716: 711: 706: 701: 696: 691: 686: 681: 676: 671: 666: 661: 656: 651: 646: 641: 636: 631: 626: 621: 620: 619: 614: 604: 599: 594: 589: 587:Norwich Pharma 584: 579: 574: 569: 564: 559: 554: 549: 544: 539: 534: 533: 532: 527: 522: 517: 507: 502: 497: 492: 487: 482: 477: 472: 467: 462: 457: 452: 447: 442: 437: 432: 427: 422: 417: 412: 407: 402: 397: 392: 387: 382: 377: 372: 367: 362: 356: 354: 350: 349: 344: 342: 341: 334: 327: 319: 307: 304: 301: 300: 271: 241: 189: 170: 139: 126:The New Yorker 111: 110: 108: 105: 68: 65: 47: 44: 27: 24: 15: 13: 10: 9: 6: 4: 3: 2: 1131: 1120: 1117: 1115: 1112: 1111: 1109: 1094: 1091: 1090: 1087: 1077: 1074: 1072: 1069: 1067: 1064: 1062: 1059: 1057: 1054: 1052: 1049: 1047: 1044: 1042: 1039: 1037: 1036:Sterling Drug 1034: 1032: 1029: 1027: 1024: 1022: 1019: 1017: 1014: 1012: 1009: 1007: 1004: 1002: 999: 997: 994: 992: 989: 987: 984: 982: 979: 977: 974: 972: 969: 967: 964: 962: 959: 957: 954: 952: 949: 947: 944: 942: 939: 937: 934: 932: 929: 927: 924: 922: 919: 917: 914: 912: 909: 907: 904: 902: 899: 897: 894: 892: 889: 887: 884: 882: 879: 877: 874: 872: 869: 867: 864: 862: 859: 857: 854: 852: 849: 848: 846: 842: 835: 834:Bausch Health 832: 829: 825: 822: 819: 815: 812: 809: 805: 802: 799: 795: 792: 789: 785: 782: 779: 775: 772: 769: 765: 762: 759: 755: 752: 749: 745: 742: 741: 739: 737: 736:Tax inversion 733: 730: 726: 720: 717: 715: 712: 710: 707: 705: 702: 700: 697: 695: 692: 690: 687: 685: 682: 680: 677: 675: 672: 670: 667: 665: 662: 660: 657: 655: 652: 650: 647: 645: 644:Purdue Pharma 642: 640: 637: 635: 632: 630: 627: 625: 622: 618: 615: 613: 610: 609: 608: 605: 603: 600: 598: 595: 593: 590: 588: 585: 583: 580: 578: 575: 573: 570: 568: 565: 563: 560: 558: 555: 553: 550: 548: 545: 543: 540: 538: 535: 531: 528: 526: 523: 521: 518: 516: 513: 512: 511: 508: 506: 503: 501: 498: 496: 493: 491: 488: 486: 483: 481: 478: 476: 473: 471: 468: 466: 463: 461: 458: 456: 453: 451: 448: 446: 443: 441: 438: 436: 433: 431: 428: 426: 423: 421: 418: 416: 413: 411: 408: 406: 403: 401: 398: 396: 393: 391: 388: 386: 383: 381: 378: 376: 373: 371: 368: 366: 363: 361: 358: 357: 355: 351: 347: 340: 335: 333: 328: 326: 321: 320: 317: 313: 312: 305: 289: 285: 278: 276: 272: 259: 252: 245: 242: 237: 233: 228: 223: 219: 215: 211: 207: 206: 201: 193: 190: 180: 179:WO 2014089053 174: 171: 159: 158: 153: 146: 144: 140: 127: 123: 116: 113: 106: 104: 102: 98: 94: 89: 85: 82: 78: 74: 66: 64: 62: 58: 54: 45: 43: 41: 37: 33: 25: 23: 21: 814:Mallinckrodt 699:Upsher-Smith 530:Ortho-McNeil 309: 291:. Retrieved 287: 262:. Retrieved 244: 209: 203: 192: 173: 161:. Retrieved 155: 130:. Retrieved 125: 115: 70: 56: 49: 29: 19: 18: 1006:Parke-Davis 689:Trevena Inc 557:Mentholatum 365:AbbVie Inc. 93:Teixobactin 73:teixobactin 67:Teixobactin 1108:Categories 1066:ViroPharma 966:Massengill 694:Ultragenyx 425:Bioverativ 107:References 88:resistance 81:pathogenic 77:antibiotic 1016:Qualitest 886:CancerVax 669:Sheffield 659:RespireRx 654:Regeneron 505:Intercept 485:Genentech 475:Eli Lilly 460:CytoSport 450:Ceragenix 293:7 January 264:7 January 258:Cambridge 163:7 January 32:Cambridge 896:CoTherix 891:Cephalon 774:Covidien 764:Allergan 754:Alkermes 674:Spectrum 542:McKesson 435:Biovista 415:BioCryst 236:25561178 97:mutation 1051:Trubion 901:Covance 881:Bradley 830:, 2013) 828:Ireland 824:Perrigo 820:, 2013) 818:Ireland 810:, 2012) 808:Ireland 800:, 2014) 798:Ireland 790:, 2014) 788:Ireland 780:, 2007) 778:Ireland 770:, 2015) 768:Ireland 760:, 2011) 758:Ireland 750:, 2013) 748:Ireland 744:Actavis 714:Viatris 612:Hospira 602:Ovation 597:Organon 592:NovaBay 577:Moderna 515:Ethicon 445:Century 430:Biovest 390:Alnylam 385:Alexion 375:Advaxis 353:Current 227:7414797 132:27 June 101:binding 57:in situ 1076:Zonite 1056:Upjohn 991:Nuvelo 986:Nereus 981:Naurex 906:Cubist 876:Biolex 861:Amylin 728:Former 709:Vertex 617:Searle 607:Pfizer 420:Biogen 410:Baxter 234:  224:  205:Nature 185:  1071:Wyeth 1061:Verus 1041:Tanox 1021:Rib-X 996:Ortho 976:Mylan 931:Genta 866:ARIAD 844:Other 684:Titan 649:Quark 495:Ionis 465:CytRx 455:Combe 395:Amgen 380:Alcon 254:(PDF) 75:, an 946:King 941:ISTA 921:Epix 871:Barr 851:Alza 295:2015 266:2015 232:PMID 165:2015 134:2016 1046:TAP 1001:OSI 288:BBC 222:PMC 214:doi 210:517 1110:: 951:KV 286:. 274:^ 256:. 230:. 220:. 208:. 202:. 154:. 142:^ 124:. 826:( 816:( 806:( 796:( 786:( 776:( 766:( 756:( 746:( 338:e 331:t 324:v 297:. 268:. 238:. 216:: 167:. 136:. 51:(

Index

Cambridge
Northeastern University
Antimicrobial Discovery Center
isolation chips
Northeastern University
teixobactin
antibiotic
pathogenic
Gram-positive bacteria
resistance
Teixobactin
mutation
binding
"The Unseen: Millions of microbes are yet to be discovered. Will one hold the ultimate cure?"


"From a Pile of Dirt, Hope for a Powerful New Antibiotic"
The New York Times
WO 2014089053
"A new antibiotic kills pathogens without detectable resistance"
Nature
doi
10.1038/nature14098
PMC
7414797
PMID
25561178
"NovoBiotic reports the discovery of teixobactin, a new antibiotic without detectable resistance"
Cambridge

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑